Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             58 results found
no title author magazine year volume issue page(s) type
1 Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis Leurs, C.E.
 2019
 28 C p. 44-49
 article
2 Acute leukocytosis during alemtuzumab treatment in patients with active relapsing-remitting multiple sclerosis Iovino, Aniello
 2019
 28 C p. 98-100
 article
3 Adherence to oral disease-modifying therapy in multiple sclerosis patients: A systematic review Yoon, Ee Ling
 2019
 28 C p. 104-108
 article
4 Altered volume and microstructural integrity of hippocampus in NMOSD Chen, Xiaoya
 2019
 28 C p. 132-137
 article
5 Anti-HSV-2 antibody in patients with MS and NMO Etemadifar, Masoud
 2019
 28 C p. 286-289
 article
6 A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child Sarigecili, Esra
 2019
 28 C p. 101-103
 article
7 A single nucleotide polymorphism in the metabotropic glutamate receptor 7 gene is associated with multiple sclerosis in Iranian population Mazdeh, Mehrdokht
 2019
 28 C p. 189-192
 article
8 Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis Giarola, Blake
 2019
 28 C p. 31-33
 article
9 Autoimmune inflammatory meningoencephalitis in a patient negative for glial fibrillary acidic protein-specific immunoglobulin G Xie, Longchang
 2019
 28 C p. 167-171
 article
10 Autonomic symptom burden can predict disease activity in early multiple sclerosis Krbot Skorić, Magdalena
 2019
 28 C p. 250-255
 article
11 Benefit evaluation in multiple sclerosis relapse treatment from the patients’ perspective – Development and validation of a new questionnaire Beckmann, Helen
 2019
 28 C p. 256-261
 article
12 Biotinidase deficiency should be considered in individuals thought to have multiple sclerosis and related disorders Wolf, Barry
 2019
 28 C p. 26-30
 article
13 Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity Masvekar, Ruturaj
 2019
 28 C p. 34-43
 article
14 Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder Zhou, Yifan
 2019
 28 C p. 213-220
 article
15 Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: A case report Aoe, Shingo
 2019
 28 C p. 165-166
 article
16 Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test) Meca-Lallana, J.E.
 2019
 28 C p. 50-56
 article
17 Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report. Arreola-Mora, C.
 2019
 28 C p. 117-124
 article
18 Erythema nodosum in a patient with multiple sclerosis on dimethyl fumarate Algahtani, Hussein
 2019
 28 C p. 155-158
 article
19 Factors associated with receiving bone mineral density screening among people with multiple sclerosis Bisson, Etienne J.
 2019
 28 C p. 305-308
 article
20 First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study Lavandier, Noëlle
 2019
 28 C p. 309-312
 article
21 First report of coexistence of MOG-antibody-positive disease and Crohn's disease Philippart, Marie
 2019
 28 C p. 1-3
 article
22 Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination Zhou, Ji
 2019
 28 C p. 4-10
 article
23 Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease Pedreño, Marta
 2019
 28 C p. 230-234
 article
24 Frequency, type, distribution of pain and related factors in persons with multiple sclerosis, Kahraman, Turhan
 2019
 28 C p. 221-225
 article
25 Geographic variations of multiple sclerosis in Iran: A population based study Hosseinzadeh, Ali
 2019
 28 C p. 244-249
 article
26 Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study Nguyen, Ai-Lan
 2019
 28 C p. 235-243
 article
27 Inequalities in access to health and social care among adults with multiple sclerosis: A scoping review of the literature Roddam, Hazel
 2019
 28 C p. 290-304
 article
28 In vivo conversion of astrocytes to oligodendrocyte lineage cells in adult mice demyelinated brains by Sox2 Farhangi, Sahar
 2019
 28 C p. 263-272
 article
29 Is the ‘MS establishment’ biased; the case for addressing gender inequality in the field of MS? Giovannoni, Gavin
 2019
 28 C p. 153-154
 article
30 Letter to the editor on “Multiple sclerosis registries in Europe – An updated mapping survey” published in Multiple Sclerosis and Related Disorder 27 (2019) 171–178 Stefan, Braune
 2019
 28 C p. 262
 article
31 Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions Mealy, Maureen A.
 2019
 28 C p. 64-68
 article
32 Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis Mohamed, Mohamed Salah
 2019
 28 C p. 226-229
 article
33 MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis Wijnands, José M.A.
 2019
 28 C p. 138-144
 article
34 Multiple sclerosis and cancer incidence: A Danish nationwide cohort study Nørgaard, M.
 2019
 28 C p. 81-85
 article
35 Multiple Sclerosis and Vitamin D – Caviar or a Dog’s Dinner? Hawkes, Chris
 2019
 28 C p. A1-A2
 article
36 Multiple sclerosis risk factors contribute to onset heterogeneity Briggs, Farren B.S.
 2019
 28 C p. 11-16
 article
37 Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases Codjia, Pekes
 2019
 28 C p. 109-116
 article
38 Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases Bibic, Vlad C.
 2019
 28 C p. 125-128
 article
39 Neurophysiological, radiological and neuropsychological evaluation of fatigue in multiple sclerosis Chalah, Moussa A.
 2019
 28 C p. 145-152
 article
40 Otolaryngological symptoms and multiple sclerosis: A forgotten and underestimated relationship Di Stadio, A.
 2019
 28 C p. 197-198
 article
41 Outcomes from acute attacks of neuromyelitis optica spectrum disorder correlate with severity of attack, age and delay to treatment Banerjee, Aditya
 2019
 28 C p. 60-63
 article
42 Patterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional study Barin, Laura
 2019
 28 C p. 17-25
 article
43 Periodized home-based training: A new strategy to improve high intensity exercise therapy adherence in mildly affected patients with Multiple Sclerosis Keytsman, Charly
 2019
 28 C p. 91-97
 article
44 Pilates for people with multiple sclerosis: A systematic review and meta-analysis Sánchez-Lastra, Miguel A.
 2019
 28 C p. 199-212
 article
45 Pregnancy outcomes in Portuguese women with multiple sclerosis: The PREGNIMS study Novo, Ana
 2019
 28 C p. 172-176
 article
46 Prevalence of asthma in multiple sclerosis: A United States population-based study Hill, Eddie
 2019
 28 C p. 69-74
 article
47 Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis Rooney, Scott
 2019
 28 C p. 276-282
 article
48 Progressive solitary sclerosis presented with diplopia: A case report Sahraian, Mohammad Ali
 2019
 28 C p. 129-131
 article
49 Pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis. Case report and literature review Demerouti, Eftychia
 2019
 28 C p. 273-275
 article
50 Risk of obstructive sleep apnea in multiple sclerosis: Frequency, clinical and radiological correlates Abdel Salam, Osama A.
 2019
 28 C p. 184-188
 article
51 Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients Liu, Tianni
 2019
 28 C p. 177-183
 article
52 Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation Martinelli, Vittorio
 2019
 28 C p. 57-59
 article
53 The proportion of peripheral regulatory T cells in patients with Multiple Sclerosis: A meta-analysis Li, Yu-Feng
 2019
 28 C p. 75-80
 article
54 Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin Lanzillo, Roberta
 2019
 28 C p. 193-196
 article
55 The role of vestibular evoked myogenic potentials in multiple sclerosis-related vertigo. A systematic review of the literature Di Stadio, Arianna
 2019
 28 C p. 159-164
 article
56 Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients Narayan, Ram N.
 2019
 28 C p. 86-90
 article
57 Unusual cortical involvement in aquaporin-4 antibody-positive patients: An analysis with double inversion recovery and phase-sensitive inversion recovery imaging Kim, Seung Woo
 2019
 28 C p. 283-285
 article
58 Vitamin D and body mass index in Egyptian multiple sclerosis patients Zamzam, Dina
 2019
 28 C p. 313-316
 article
                             58 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands